Skip to content

Switzerland English logo

Main menu
    • About us
    • Our vision
    • Our values
    • Environmental, Social & Governance (ESG)
    • Organon GmbH – Transparenz
  • Our areas of focus
  • Media/Press
  • Join our team
  • Contact Us

Back
Change Language
  • Contact Us
  • Deutsch
  • Français
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Organon Illustration von fünf Frauen unterschiedlicher Nationalitäten

Our Vision

A Better and Healthier Life – Every Day for Every Woman

Organon – Women’s Health Partner and Expert

Since June 2021, the new company Organon, with around 10,000 employees worldwide in nearly 60 countries and six of its own production sites, has been committed to a better and healthier life – every day for every woman. With more than 60 products from our three Women’s Health, Biosimilars, and Established Products divisions, we have sales potential of more than six billion US dollars.

Until 2009, the name Organon represented innovations in contraception. We are building on this tradition. With ten established products specifically for women, we are already one of the major players in this sector. As an expert organization, we want to engage in long-term research and development, as a partner, but also in the public debate for women’s health.

Our Name and Logo

“Organon” is a collection of writings by the Greek philosopher Aristotle, in which he describes the art of logic as a tool of science (Greek: Organon). Since then, “Organon” has been understood to mean “an instrument for the acquisition of knowledge.”

“Organon” was first chosen as the name of a Dutch pharmaceutical company founded in 1923, which stood for advances in women’s health like no other, with novel treatments like of the first birth control pills or an innovative vaginal ring.

In 2007, the Dutch company Organon was acquired by Schering-Plough and in 2009 became part of MSD (known in the U.S. as Merck & Co. Inc., based in Kenilworth, NJ) after a merger. In Switzerland, Schering-Plough operated under the name Essex Chemie. We chose the name “Organon” because we want to build on the tradition of this pioneer in women’s health and surpass that legacy with innovative treatments that benefit women around the world.

The Organon logo shows a pattern of dots and dashes. The colored dots represent our different divisions, with the central dot symbolizing our focus, women’s health.

The lines represent our vision and values, including a commitment to improving people’s lives and, in particular, contributing to a better and healthier life for women. Together, the geometric shapes form a logo designed to convey both our tradition and our values and vision for the future as a distinctive and compelling whole.

Illustration einer Gruppe von drei Frauen

Our Values

Our Vision: A Better and Healthier Life – Every Day for Every Woman

Our Community

Together we stand strong to address the special healthcare needs of women

We are a global community with thousands of committed people. We are united in our dedication to promote women’s health around the world.

Organon Illustration einer Videokonferenz

Unsere Standorte

Germany, Austria, Switzerland

Germany
Organon Healthcare GmbH
Neuturmstrasse 5
80331 Munich

Austria
Organon Austria GmbH
Kärntner Ring 12
1010 Vienna

Switzerland
Organon GmbH
Weystrasse 20
6006 Lucerne

CH-NON-110045

Switzerland English logo
  • Publisher
  • Terms of Use
  • AGB
  • Cookie Policy
  • Privacy Policy
© 2025 Organon group of companies. All rights reserved.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept